27 CGT therapies sold nearly 20 billion yuan (2024 Q1)

The State Drug Administration has led the investigation of the progress in the research and development of cell and gene therapy products. More than 400 cell and gene therapy products across the country are conducting drug clinical trials.

CCTV reported that stem cells cured rheumatoid disease for 11 years. How to save themselves in patients with rheumatoid arthritis

In 2024, cell gene therapy is expected to be approved by FDA in the United States.

Recently, the Drug examination Center (CDE) of the State Drug Administration has accepted a total of 87 mesenchymal stem cell-related drugs and 59 implied clinical permits.

In April 2024, the Drug examination Center of the State Drug Administration (CDE) accepted a total of 2 new stem cell-related drugs with implied clinical license.

Shenyang successfully obtains "international visa" for cord blood and adult stem cells

Review of Stem Cell Policy at a Glance (Updated policy 2023 and 2024)